SCHEMBL28499596

SCHEMBL28499596

CN1CCN(c2c(F)cc(B3OC(C)(C)C(C)(C)O3)cc2F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.39
LPL P06858 6/20 0.38
LIPG Q9Y5X9 6/20 0.38
MAPT P10636 1/20 0.37
KDM4E B2RXH2 7/20 0.33
ADRA2B P18089 1/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 4/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 3/20 0.32
HSD17B10 Q99714 3/20 0.32
HRH4 Q9H3N8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
ALB P02768 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
TUBB4A P04350 1/20 0.31
POLB P06746 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24722942 0.92 ROCK1 (0.37) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL13958143 0.90 MAPT (0.39) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL28502430 0.88 CCR4 (0.36) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL428655 0.87 ROCK1 (0.34) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL24723411 0.83 LPL (0.33) LPLLIPGMAPTKDM4EMAPK1
SCHEMBL29776667 0.81 ROCK1 (0.45) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL13717591 0.81 ROCK1 (0.45) ROCK1LPLLIPGMAPTKDM4E
SCHEMBL28514928 0.79 CCR4 (0.39) HRH4SMN1; SMN2
SCHEMBL24722841 0.78 HRH4 (0.35) LPLLIPGMAPTKDM4EHRH4
SCHEMBL24723265 0.77 CYP1A2 (0.34) LPLLIPGKDM4EMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382277-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543887-A2 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382277-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 ROCK1 1977/4885LPL 4312/4885LIPG 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.